AQIX LTD
AQIX LTD is a privately held UK biotech (founded 1998, Canterbury) that develops fluid solutions for the ex vivo preservation and transport of cells, tissues, and organs. No active operations, products, customers, or revenue could be verified from the available data.
- Company typePrivate
- Founded1998
- HeadquartersCanterbury, United Kingdom
- Headcount—
- GTM typeB2B
- OfferingHardware or Manufacturing
AQIX LTD firmographics
Firmographics- Name
- AQIX LTD
- Website
- https://aqix.com
- Company type
- Private
- Founded year
- 1998
- Short description
- AQIX LTD is a privately held UK biotech (founded 1998, Canterbury) that develops fluid solutions for the ex vivo preservation and transport of cells, tissues, and organs. No active operations, products, customers, or revenue could be verified from the available data.
- Ownership category
- akta.pro rank
AQIX LTD industry classification
Industry- Product category
- Organ & Tissue Preservation Media
- NAICS
- Pharmaceutical and Medicine Manufacturing (32541), Medicinal and Botanical Manufacturing (325411)
- SIC
- Medicinal Chemicals & Botanical Products (2833), Miscellaneous Chemical Products (2890)
- akta.pro primary industry
- Raw Materials & Critical Reagents Supply (Media/Resins/Cytokines) (HLAGAGAI)
- akta.pro secondary industries
- Cell Culture & Bioprocess Lab Equipment (Bioreactors, Single-Use Systems, Controllers) (HLAGAIAG), Raw Materials & Critical Reagents Supply Services (media, resins, single-use) (HLAAAKAI), Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)
Keywords
Where AQIX LTD is headquartered
LocationHeadquarters
- HQ city
- Canterbury
- HQ country
- United Kingdom
- HQ region
- Europe
Markets served
AQIX LTD business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Supply Chain
AQIX LTD product offering
Product offeringCore offering
AQIX LTD develops biotechnological fluid solutions used for the ex vivo preservation and transport of cells, tissues, and organs. The product portfolio is positioned for medical, research, and transplantation-sector buyers that require specialized media to maintain biological material viability outside the body.
Differentiator
Problem solved
Functional benefit
Products and services
- AQIX Biotechnological Preservation Fluid Solutions
Companies that use AQIX LTD
Customer profileIdeal customer profiles1 record
AQIX LTD technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AQIX LTD competitors and assessment
Company assessmentBroad incumbents
- Lonza Group: Global cell and gene therapy manufacturer offering media, buffers, and biopreservation solutions; relevant comparator at the upstream reagent/preservation-fluid layer.
- Sartorius: Supplies bioprocessing media, single-use systems, and cell therapy manufacturing solutions; adjacent incumbent in the preservation/reagent value chain.
- Cryoport Systems: Provides integrated cold-chain logistics and biopreservation solutions for cell therapies and reproductive medicine — broader portfolio but overlapping preservation/transport use cases.
- Cytiva: Large bioprocessing supplier offering cell culture media, buffers, and biopreservation reagents; overlaps AQIX's reagent/media category through a much broader portfolio.
Direct peers
- BioLife Solutions: Supplies cryopreservation and biopreservation media (e.g., CryoStor, HypoThermosol) for cell therapies and regenerative medicine — directly comparable to AQIX's preservation-fluid focus.
- TransMedics: Organ-care and ex vivo preservation/transport systems for lung, heart, and liver transplants — direct adjacency to AQIX's organ preservation fluid application.
- Paragonix Technologies: Specialises in donor organ preservation and transport devices and consumables for thoracic and abdominal transplants — comparable niche to AQIX.
- OrganOx: Develops ex vivo organ preservation and perfusion technology for transplant logistics, overlapping with AQIX's stated scope of organ preservation and transport fluids.
- XVIVO Perfusion: Ex vivo organ perfusion and preservation systems and solutions for lung and other organ transplants, addressing the same clinical use cases AQIX targets.
Emerging players
- Atelerix: UK-based developer of hydrogel-based cell and tissue preservation technology; comparable application area (ex vivo cell/tissue preservation) and similar UK origin.
Market position
Customer concentration
AQIX LTD social profiles
Digital presenceAQIX LTD financial estimates
Financial estimateRevenue estimate
Valuation estimate
AQIX LTD leadership team
Management profileNumber of profiles
AQIX LTD funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
AQIX LTD M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about AQIX LTD
What does AQIX LTD do?
AQIX LTD develops biotechnological fluid solutions used for the ex vivo preservation and transport of cells, tissues, and organs. The product portfolio is positioned for medical, research, and transplantation-sector buyers that require specialized media to maintain biological material viability outside the body.
When was AQIX LTD founded?
AQIX LTD was founded in 1998.
Where is AQIX LTD based?
AQIX LTD is headquartered in Canterbury, United Kingdom, in the Europe region.
Who are AQIX LTD's main competitors?
Broad incumbents on record are Lonza Group, Sartorius, Cryoport Systems and Cytiva. Direct peers are BioLife Solutions, TransMedics, Paragonix Technologies, OrganOx and XVIVO Perfusion. Atelerix is listed as an emerging player.
Does AQIX LTD have an API?
No public API is recorded for AQIX LTD.
What industry is AQIX LTD in?
AQIX LTD's product category is Organ & Tissue Preservation Media. Its primary akta.pro industry code is HLAGAGAI, Raw Materials & Critical Reagents Supply (Media/Resins/Cytokines), with a secondary code of HLAGAIAG, Cell Culture & Bioprocess Lab Equipment (Bioreactors, Single-Use Systems, Controllers). Its NAICS code is 32541 and its SIC code is 2833.